Table 3 Survival analysis considering the primary outcome and ITT analysis for 24 months of follow-up
Trial groups | Survival proportion % | SE | HR (95%CI) | p |
|---|---|---|---|---|
Survival analysis (primary outcome) | ||||
Hand-mixed group | 60.9 | 0.04 | 1.00 | 0.626* |
Encapsulated group | 59.3 | 0.05 | 0.91 (0.61 to 1.35) | |
Trial groups | Success | Failure | RR (95%CI) | p |
|---|---|---|---|---|
N (%) | N (%) | |||
Success at 24 months (intention to treat analysis) | ||||
Hand-mixed group | 100 (62.1) | 61 (37.8) | 1.00 | 0.498** |
Encapsulated group | 99 (61.1) | 63 (38.9) | 0.88 (0.62 to 1.26) | |